SCA14
MCID: SPN075
MIFTS: 38

Spinocerebellar Ataxia Type 14 (SCA14) malady

Genetic diseases, Rare diseases, Neuronal diseases, Eye diseases, Mental diseases, Skin diseases, Muscle diseases categories

Summaries for Spinocerebellar Ataxia Type 14

About this section
Sources:
48OMIM, 20GeneReviews, 34MalaCards
See all sources

Fully expand this MalaCard

Download this MalaCard
MalaCards: Spinocerebellar Ataxia Type 14, also known as spinocerebellar ataxia 14, is related to spinocerebellar ataxia and ataxia. An important gene associated with Spinocerebellar Ataxia Type 14 is PRKCG (protein kinase C, gamma), and among its related pathways are CDK-mediated phosphorylation and removal of Cdc6 and Nanog in Mammalian ESC Pluripotency. The compounds gf 109203x and nmda have been mentioned in the context of this disorder. Related mouse phenotypes are nervous system and behavior/neurological.

Description from OMIM:48 605361

GeneReviews summary for sca14

Aliases & Classifications for Spinocerebellar Ataxia Type 14

About this section
Sources:
20GeneReviews, 44NIH Rare Diseases, 23GTR, 48OMIM, 46Novoseek, 50Orphanet, 63UMLS, 37MESH via Orphanet, 27ICD10 via Orphanet, 64UMLS via Orphanet
See all sources

Classifications:



Characteristics (Orphanet epidemiological data):

50
sca14:
Inheritance: Autosomal dominant; Prevalence: <1/1000000


Aliases & Descriptions:

spinocerebellar ataxia type 14 20 44 50
spinocerebellar ataxia 14 44 23 48 63
sca14 20 44 46 50


External Ids:

OMIM48 605361
MESH via Orphanet37 C537196
ICD10 via Orphanet27 G11
UMLS via Orphanet64 C1854369

Related Diseases for Spinocerebellar Ataxia Type 14

About this section
Sources:
18GeneCards, 19GeneDecks
See all sources

Graphical network of diseases related to Spinocerebellar Ataxia Type 14:



Diseases related to spinocerebellar ataxia type 14

Symptoms for Spinocerebellar Ataxia Type 14

About this section
Sources:
48OMIM
See all sources

Symptoms by clinical synopsis from OMIM:

605361

Clinical features from OMIM:

605361

Drugs & Therapeutics for Spinocerebellar Ataxia Type 14

About this section
Sources:
6CenterWatch, 43NIH Clinical Center, 7ClinicalTrials, 63UMLS, 42NDF-RT
See all sources

Approved drugs:

Search CenterWatch for Spinocerebellar Ataxia Type 14

Drug clinical trials:

Search ClinicalTrials for Spinocerebellar Ataxia Type 14

Search NIH Clinical Center for Spinocerebellar Ataxia Type 14

Search CenterWatch for Spinocerebellar Ataxia Type 14

Genetic Tests for Spinocerebellar Ataxia Type 14

About this section
Sources:
23GTR
See all sources

Genetic tests related to Spinocerebellar Ataxia Type 14:

id Genetic test Affiliating Genes
1 Spinocerebellar Ataxia 1423

Anatomical Context for Spinocerebellar Ataxia Type 14

About this section

Animal Models for Spinocerebellar Ataxia Type 14 or affiliated genes

About this section
Sources:
38MGI
See all sources

MGI Mouse Phenotypes related to Spinocerebellar Ataxia Type 14:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00036318.5PRKCG, SGCE, HSPA4
2MP:00053868.2PRKCG, SGCE, HSPA4

Publications for Spinocerebellar Ataxia Type 14

About this section
Sources:
53PubMed
See all sources

Articles related to Spinocerebellar Ataxia Type 14:

(show all 23)
idTitleAuthorsYear
1
Clinical and neurophysiological profile of four german families with spinocerebellar ataxia type 14. (24030789)
2014
2
Cognition is only minimally impaired in Spinocerebellar ataxia type 14 (SCA14): a neuropsychological study of ten Norwegian subjects compared to intrafamilial controls and population norm. (24289098)
2013
3
A novel mutation in the C2 domain of protein kinase C gamma associated with spinocerebellar ataxia type 14. (23604456)
2013
4
Mutant I^PKC that causes spinocerebellar ataxia type 14 upregulates Hsp70, which protects cells from the mutant's cytotoxicity. (24021284)
2013
5
Spinocerebellar ataxia type 14. (21827914)
2012
6
Mutant PKCI^ in spinocerebellar ataxia type 14 disrupts synapse elimination and long-term depression in Purkinje cells in vivo. (21976518)
2011
7
Myoclonus-dystonia and spinocerebellar ataxia type 14 presenting with similar phenotypes: trunk tremor, myoclonus, and dystonia. (19913450)
2010
8
Congo red, an amyloid-inhibiting compound, alleviates various types of cellular dysfunction triggered by mutant protein kinase cI^ that causes spinocerebellar ataxia type 14 (SCA14) by inhibiting oligomerization and aggregation. (20938103)
2010
9
Mutant protein kinase C gamma that causes spinocerebellar ataxia type 14 (SCA14) is selectively degraded by autophagy. (20398063)
2010
10
Effect of trehalose on the properties of mutant {gamma}PKC, which causes spinocerebellar ataxia type 14, in neuronal cell lines and cultured Purkinje cells. (20705605)
2010
11
Mutant gammaPKC found in spinocerebellar ataxia type 14 induces aggregate-independent maldevelopment of dendrites in primary cultured Purkinje cells. (19041943)
2009
12
PKC gamma mutations in spinocerebellar ataxia type 14 affect C1 domain accessibility and kinase activity leading to aberrant MAPK signaling. (18577575)
2008
13
Another mutation in cysteine 131 in protein kinase C gamma as a cause of spinocerebellar ataxia type 14. (17562946)
2007
14
Aggregate formation of mutant protein kinase C gamma found in spinocerebellar ataxia type 14 impairs ubiquitin-proteasome system and induces endoplasmic reticulum stress. (18005063)
2007
15
Identification of a new family of spinocerebellar ataxia type 14 in the Japanese spinocerebellar ataxia population by the screening of PRKCG exon 4. (16763984)
2006
16
A novel H101Q mutation causes PKCgamma loss in spinocerebellar ataxia type 14. (16189624)
2005
17
Mutant protein kinase Cgamma found in spinocerebellar ataxia type 14 is susceptible to aggregation and causes cell death. (15964845)
2005
18
Spinocerebellar ataxia type 14: study of a family with an exon 5 mutation in the PRKCG gene. (16291902)
2005
19
New mutations in protein kinase Cgamma associated with spinocerebellar ataxia type 14. (16193476)
2005
20
Spinocerebellar ataxia type 14: opening a new door in dominant ataxia research? (15824330)
2005
21
Mutation in the catalytic domain of protein kinase C gamma and extension of the phenotype associated with spinocerebellar ataxia type 14. (15313841)
2004
22
Spinocerebellar ataxia type 14 caused by a mutation in protein kinase C gamma. (14676051)
2003
23
Spinocerebellar Ataxia Type 14 (20301573)
1993

Variations for Spinocerebellar Ataxia Type 14

About this section
Sources:
65UniProtKB/Swiss-Prot, 1 National Center for Biotechnology Information (Clinvar)
See all sources

UniProtKB/Swiss-Prot genetic disease variations for Spinocerebellar Ataxia Type 14:

65
id Symbol AA change Variation ID SNP ID
1PRKCGp.His101TyrVAR_017060
2PRKCGp.Ser119ProVAR_017061
3PRKCGp.Gly128AspVAR_017062

Clinvar genetic disease variations for Spinocerebellar Ataxia Type 14:

1 (show all 27)
id Gene Name Type Significance SNP ID Assembly Location
1PRKCGNM_002739.3(PRKCG): c.301C> T (p.His101Tyr)single nucleotide variantPathogenicrs121918511GRCh37Chr 19, 54392907: 54392907
2PRKCGNM_002739.3(PRKCG): c.355T> C (p.Ser119Pro)single nucleotide variantPathogenicrs121918512GRCh37Chr 19, 54392961: 54392961
3PRKCGNM_002739.3(PRKCG): c.383G> A (p.Gly128Asp)single nucleotide variantPathogenicrs121918513GRCh37Chr 19, 54392989: 54392989
4PRKCGNM_002739.3(PRKCG): c.353G> A (p.Gly118Asp)single nucleotide variantPathogenicrs121918514GRCh37Chr 19, 54392959: 54392959
5PRKCGNM_002739.3(PRKCG): c.380A> G (p.Gln127Arg)single nucleotide variantPathogenicrs121918515GRCh37Chr 19, 54392986: 54392986
6PRKCGNM_002739.3(PRKCG): c.1927T> C (p.Phe643Leu)single nucleotide variantPathogenicrs121918516GRCh37Chr 19, 54409982: 54409982
7PRKCGNM_002739.3(PRKCG): c.1081A> G (p.Ser361Gly)single nucleotide variantPathogenicrs121918517GRCh37Chr 19, 54401354: 54401354
8PRKCGNM_002739.3(PRKCG): c.303C> G (p.His101Gln)single nucleotide variantPathogenicrs121918518GRCh37Chr 19, 54392909: 54392909
9PRKCGNM_002739.3: c.2091_*98del102deletionPathogenicGRCh37Chr 19, 54410146: 54410247
10PRKCGPRKCG, 1,717-BP DELdeletionPathogenic
11PRKCGNM_002739.3(PRKCG): c.1438G> T (p.Asp480Tyr)single nucleotide variantPathogenicrs387906679GRCh37Chr 19, 54403866: 54403866
12PRKCGNM_002739.3(PRKCG): c.1078G> A (p.Gly360Ser)single nucleotide variantPathogenicrs386134171GRCh37Chr 19, 54401351: 54401351
13PRKCGNM_002739.3(PRKCG): c.122G> C (p.Arg41Pro)single nucleotide variantPathogenicrs386134158GRCh37Chr 19, 54385870: 54385870
14PRKCGNM_002739.3(PRKCG): c.188G> T (p.Gly63Val)single nucleotide variantPathogenicrs386134159GRCh37Chr 19, 54386434: 54386434
15PRKCGNM_002739.3(PRKCG): c.2075T> G (p.Val692Gly)single nucleotide variantPathogenicrs78437096GRCh37Chr 19, 54410130: 54410130
16PRKCGNM_002739.3(PRKCG): c.229T> A (p.Cys77Ser)single nucleotide variantPathogenicrs386134160GRCh37Chr 19, 54387441: 54387441
17PRKCGNM_002739.3(PRKCG): c.296_301delACAAAC (p.His101_Lys102del)deletionPathogenicrs386134161GRCh37Chr 19, 54392902: 54392907
18PRKCGNM_002739.3(PRKCG): c.341G> A (p.Cys114Tyr)single nucleotide variantPathogenicrs386134162GRCh37Chr 19, 54392947: 54392947
19PRKCGNM_002739.3(PRKCG): c.356C> T (p.Ser119Phe)single nucleotide variantPathogenicrs386134163GRCh37Chr 19, 54392962: 54392962
20PRKCGNM_002739.3(PRKCG): c.367G> A (p.Gly123Arg)single nucleotide variantPathogenicrs386134164GRCh37Chr 19, 54392973: 54392973
21PRKCGNM_002739.3(PRKCG): c.368G> A (p.Gly123Glu)single nucleotide variantPathogenicrs386134165GRCh37Chr 19, 54392974: 54392974
22PRKCGNM_002739.3(PRKCG): c.391T> C (p.Cys131Arg)single nucleotide variantPathogenicrs386134166GRCh37Chr 19, 54392997: 54392997
23PRKCGNM_002739.3(PRKCG): c.392G> A (p.Cys131Tyr)single nucleotide variantPathogenicrs386134167GRCh37Chr 19, 54392998: 54392998
24PRKCGNM_002739.3(PRKCG): c.413T> A (p.Val138Glu)single nucleotide variantPathogenicrs386134168GRCh37Chr 19, 54393155: 54393155
25PRKCGNM_002739.3(PRKCG): c.449_450delGCinsTT (p.Cys150Phe)indelPathogenicrs386134170GRCh37Chr 19, 54393191: 54393192
26PRKCGNM_002739.3(PRKCG): c.417C> A (p.His139Gln)single nucleotide variantPathogenicrs386134169GRCh37Chr 19, 54393159: 54393159
27PRKCGNM_002739.3(PRKCG): c.76A> G (p.Arg26Gly)single nucleotide variantPathogenicrs386134157GRCh37Chr 19, 54385824: 54385824

Expression for genes affiliated with Spinocerebellar Ataxia Type 14

About this section
Sources:
2BioGPS, 16Gene Expression Omnibus DataSets
See all sources
Expression patterns in normal tissues for genes affiliated with Spinocerebellar Ataxia Type 14

Search GEO for disease gene expression data for Spinocerebellar Ataxia Type 14.

Pathways for genes affiliated with Spinocerebellar Ataxia Type 14

About this section
Sources:
51PathCards, 56Reactome, 39NCBI BioSystems Database, 61Thomson Reuters, 31KEGG, 54QIAGEN
See all sources

Pathways related to Spinocerebellar Ataxia Type 14 according to GeneCards/GeneDecks:

idSuper pathways (with members indented)ScoreTop Affiliating Genes
1
Show member pathways
Proteasome Degradation39
Immune response Antigen presentation by MHC class I61
9.3PRKCG, HSPA4
2
Show member pathways
9.3PRKCG, HSPA4
3
Show member pathways
9.3PRKCG, HSPA4

Compounds for genes affiliated with Spinocerebellar Ataxia Type 14

About this section
Sources:
46Novoseek, 62Tocris Bioscience, 30IUPHAR, 25HMDB, 12DrugBank
See all sources

Compounds related to Spinocerebellar Ataxia Type 14 according to GeneCards/GeneDecks:

idCompoundScoreTop Affiliating Genes
1gf 109203x46 6210.4PRKCG, HSPA4
2nmda46 3010.4PRKCG, HSPA4
3dopamine46 30 25 1212.3PRKCG, HSPA4
4atp46 3010.3PRKCG, HSPA4
5glutamate469.2HSPA4, PRKCG
6adp46 30 2511.0PRKCG, HSPA4

GO Terms for genes affiliated with Spinocerebellar Ataxia Type 14

About this section

Products for genes affiliated with Spinocerebellar Ataxia Type 14

About this section
  • Antibodies
  • Proteins
  • Lysates
  • Antibodies

Sources for Spinocerebellar Ataxia Type 14

About this section
4CDC
14ExPASy
15FMA
23GTR
24HGMD
25HMDB
26ICD10
27ICD10 via Orphanet
28ICD9CM
30IUPHAR
31KEGG
36MeSH
37MESH via Orphanet
38MGI
41NCIt
42NDF-RT
45NINDS
46Novoseek
48OMIM
49OMIM via Orphanet
53PubMed
54QIAGEN
60SNOMED-CT via Orphanet
63UMLS
64UMLS via Orphanet